Pharmafile Logo
Pharmafocus logo
Advanced Search
Boehringer Ingelheim and Lilly's diabetes drug Tradjenta

Boehringer-Lilly launch diabetes drug Tradjenta in US

June 16, 2011
Sales and Marketing Boehringer Ingelheim, Tradjenta, diabetes, lilly

Boehringer Ingelheim and Eli Lilly’s new type II diabetes treatment Tradjenta has been launched in the US. Tradjenta (linagliptin) is …

News

RSA expands

June 16, 2011
Business Services appointment, business services

Global life sciences executive search and interim management firm RSA has made a series of new appointments across its business. …

Appointment

UK government confirms major amendments to Health Bill

June 15, 2011
Health and Social Care Bill, NHS reforms

The government will make major amendments to its controversial Health and Social Care Bill, including minimising the scope of regulator …

News

GSK takes control of China vaccines venture

June 15, 2011
Manufacturing and Production, Research and Development, Sales and Marketing China, GSK, Shenzhen Neptunus Interlong Bio-Technique Co, vaccines

GlaxoSmithKline is increasing its footprint in China, shelling out £24 million ($39 million) to buy the remaining stake in a …

News

Arecor and GSK collaborate on vaccine technology

June 15, 2011
Manufacturing and Production, Research and Development Arecor, GSK, vaccines

GSK is to team up with UK company Arecor to develop advanced formulations of GSK’s vaccines. Cambridge-based Arecor has developed …

News
ABPI social media internet guidelines

Digital Pharma: Pharmacovigilance, the internet and social media

June 15, 2011
Medical Communications, Research and Development, Sales and Marketing Digital Pharma blog, adverse event reporting, adverse events, pharmacovigilance

This week the ABPI released guidance on managing adverse events from social media and the internet in a document that …

Feature
Cephalon

Teva’s Cephalon acquisition could be delayed

June 15, 2011
Manufacturing and Production, Research and Development, Sales and Marketing Cephalon, Teva

The Federal Trade Commission has requested more information about Teva’s deal with Cephalon, potentially delaying the purchase by a month. …

News
Merck & Co

Merck to develop biosimilar of Pfizer’s Enbrel

June 15, 2011
Research and Development, Sales and Marketing Enbrel, Merck & Co, biosimilar

Merck & Co is to develop its own version of Pfizer’s ageing arthritis drug Enbrel with a South Korean manufacturer. …

News

Future Forum recommends major amendments to Health Bill

June 14, 2011
Health and Social Care Bill, NHS reforms

The role of GPs and competition in the government’s Health Bill should be greatly diluted and its reform programme substantially …

News

Xceleron appoints Dr Stuart Best

June 14, 2011
Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development

Dr Stuart Best has joined Xceleron as senior director operations, moving to the company from Merck in Scotland where he …

Appointment

FDA plea for notice on drug shortages

June 14, 2011
Manufacturing and Production FDA, pharma manufacturing

The FDA has asked US drugmakers to give advance warning of production problems which could lead to shortages in available …

News

Pharma manufacturing news in brief

June 14, 2011
Manufacturing and Production pharma manufacturing

Baxter loses first heparin lawsuit, Pfizer plans a branded generics push in China, plus there’s updates from GSK, Hovione and …

News
Pfizer's Sandwich, Kent research site

Pfizer’s Sandwich site on market as ‘discovery park’

June 14, 2011
Research and Development Pfizer, Sandwich, UK pharma

Pfizer has expanded its options for its main European research site, earmarked for closure in Feburary, and is now marketing …

News

Merck redesigns drug labels for clarity

June 14, 2011
Manufacturing and Production FDA, Labelling, Merck & Co

The FDA has approved a major overhaul of labelling for a range of Merck & Co products, paving the way …

News
Blog footer

Digital Pharma: The rise of the European e-patient

June 14, 2011
Medical Communications, Sales and Marketing Digital Pharma blog, online health information

The number of people in Europe who go online to look for health information has more than doubled over the …

News

Innovation – is it science or art?

June 14, 2011
Manufacturing and Production, Research and Development creativity, drug development, innovation

In recent times new drug development has shown a substantial decline in the number of approved drugs for human use. …

Feature

Gilead manufacturing under investigation by US authorities

June 14, 2011
Manufacturing and Production Department of Justice, Gilead, manufacturing compliance, pharma manufacturing

Gilead Sciences is being investigated by the US authorities over the manufacturing and distribution of some of its products, and …

News

Brand(x) rebrands to ICC Lowe

June 13, 2011
Medical Communications Brand(x), ICC Lowe, medical communications

Brand(x) is changing its name to ICC Lowe and will act as the London office for its expanding US parent …

News

Merck KGaA readies phase III brain cancer trial

June 13, 2011
Research and Development Merck KGaA, brain cancer, cilengitide, glioblastoma

Merck KGaA has completed patient enrollment for a phase III global trial of its first-in-class integrin inhibitor in a rare …

News

Daniel Elger joins e-Therapeutics

June 13, 2011
Research and Development, Sales and Marketing appointment, research and development, sales and marketing

UK and India-based e-Therapeutics has appointed Dr Daniel Elger as chief financial officer. He joins the drug discovery company from …

Appointment
The Gateway to Local Adoption Series

Latest content

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026